CYPHERPUNK TECHNOLOGIES INC. Stock-Based Compensation
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Stock-Based Compensation of $4.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-12
- CYPHERPUNK TECHNOLOGIES INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.16M, a 45.00% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.13M, a 76.99% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.90M, a 23.01% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $303.00K, a 77.37% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. share-based payment arrangement, noncash expense for fiscal 2025 was $4.90M, a 10.99% decline from fiscal 2024.
- CYPHERPUNK TECHNOLOGIES INC. share-based payment arrangement, noncash expense for fiscal 2024 was $5.50M, a 7.33% increase from fiscal 2023.
- CYPHERPUNK TECHNOLOGIES INC. share-based payment arrangement, noncash expense for fiscal 2023 was $5.13M, a 1.00% decline from fiscal 2022.
- CYPHERPUNK TECHNOLOGIES INC. share-based payment arrangement, noncash expense for fiscal 2022 was $5.18M, a 40.53% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $4.29M 10-Q · filed 2026-08-12 | $6.19M derived: sum of 3 quarters · filed 2026-08-12 | $6.50M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $2.13M 10-Q · filed 2026-05-14 | $4.03M derived: sum of 2 quarters · filed 2026-05-14 | $4.34M derived: sum of 3 quarters · filed 2026-05-14 | $5.83M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.21M derived: sum of 2 quarters · filed 2026-03-16 | $3.69M derived: sum of 3 quarters · filed 2026-08-12 | $4.90M 10-K · filed 2026-03-16 |
| 2025-09-30 | $303.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.79M derived: sum of 2 quarters · filed 2026-08-12 | $3.00M 10-Q · filed 2025-11-12 | $4.54M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $2.69M 10-Q · filed 2026-08-12 | $4.24M derived: sum of 3 quarters · filed 2026-08-12 | $5.58M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $1.20M 10-Q · filed 2026-05-14 | $2.75M derived: sum of 2 quarters · filed 2026-05-14 | $4.09M derived: sum of 3 quarters · filed 2026-05-14 | $5.46M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.89M derived: sum of 2 quarters · filed 2026-03-16 | $4.26M derived: sum of 3 quarters · filed 2026-03-16 | $5.50M 10-K · filed 2026-03-16 |
| 2024-09-30 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.71M derived: sum of 2 quarters · filed 2025-11-12 | $3.96M 10-Q · filed 2025-11-12 | $5.21M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $2.62M 10-Q · filed 2025-08-14 | $3.87M derived: sum of 3 quarters · filed 2025-08-14 | $5.17M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $1.25M 10-Q · filed 2025-05-13 | $2.50M derived: sum of 2 quarters · filed 2025-05-13 | $3.80M derived: sum of 3 quarters · filed 2025-05-13 | $5.07M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $2.55M derived: sum of 2 quarters · filed 2025-03-26 | $3.82M derived: sum of 3 quarters · filed 2025-03-26 | $5.13M 10-K · filed 2025-03-26 |
| 2023-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $2.56M derived: sum of 2 quarters · filed 2024-11-13 | $3.88M 10-Q · filed 2024-11-13 | $5.33M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $2.58M 10-Q · filed 2024-08-12 | $4.03M derived: sum of 3 quarters · filed 2024-08-12 | $5.29M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $1.31M 10-Q · filed 2024-05-13 | $2.77M derived: sum of 2 quarters · filed 2024-05-13 | $4.02M derived: sum of 3 quarters · filed 2024-05-13 | $5.29M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $2.71M derived: sum of 2 quarters · filed 2024-03-18 | $3.98M derived: sum of 3 quarters · filed 2024-03-18 | $5.18M 10-K · filed 2024-03-18 |
| 2022-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.52M derived: sum of 2 quarters · filed 2023-11-13 | $3.72M 10-Q · filed 2023-11-13 | $4.66M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.47M 10-Q · filed 2023-08-14 | $3.41M derived: sum of 3 quarters · filed 2023-08-14 | $4.41M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.20M 10-Q · filed 2023-05-15 | $2.14M derived: sum of 2 quarters · filed 2023-05-15 | $3.15M derived: sum of 3 quarters · filed 2023-05-15 | $4.06M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $938.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $1.94M derived: sum of 2 quarters · filed 2023-03-24 | $2.85M derived: sum of 3 quarters · filed 2023-03-24 | $3.69M 10-K · filed 2023-03-24 |
| 2021-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.92M derived: sum of 2 quarters · filed 2022-11-14 | $2.75M 10-Q · filed 2022-11-14 | $3.46M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $912.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.75M 10-Q · filed 2022-08-12 | $2.46M derived: sum of 3 quarters · filed 2022-08-12 | $3.13M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $833.00K 10-Q · filed 2022-05-13 | $1.55M derived: sum of 2 quarters · filed 2022-05-13 | $2.22M derived: sum of 3 quarters · filed 2022-05-13 | $2.83M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $715.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.39M derived: sum of 2 quarters · filed 2022-03-11 | $2.00M derived: sum of 3 quarters · filed 2022-03-11 | $2.57M 10-K · filed 2022-03-11 |
| 2020-09-30 | $670.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.29M derived: sum of 2 quarters · filed 2021-11-12 | $1.86M 10-Q · filed 2021-11-12 | $2.79M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $617.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $1.19M 10-Q · filed 2021-08-13 | $2.12M derived: sum of 3 quarters · filed 2021-08-13 | $3.07M derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $570.00K 10-Q · filed 2021-05-14 | $1.51M derived: sum of 2 quarters · filed 2021-05-14 | $2.46M derived: sum of 3 quarters · filed 2021-05-14 | $3.35M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $936.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.89M derived: sum of 2 quarters · filed 2021-03-12 | $2.79M derived: sum of 3 quarters · filed 2021-03-12 | $3.73M 10-K · filed 2021-03-12 |
| 2019-09-30 | $950.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $1.85M derived: sum of 2 quarters · filed 2020-11-12 | $2.80M 10-Q · filed 2020-11-12 | $3.72M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $899.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $1.85M 10-Q · filed 2020-08-13 | $2.77M derived: sum of 3 quarters · filed 2020-08-13 | $3.70M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $947.00K 10-Q · filed 2020-05-14 | $1.87M derived: sum of 2 quarters · filed 2020-05-14 | $2.80M derived: sum of 3 quarters · filed 2020-05-14 | $3.69M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $925.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $1.86M derived: sum of 2 quarters · filed 2020-03-16 | $2.74M derived: sum of 3 quarters · filed 2020-03-16 | $3.47M 10-K · filed 2020-03-16 |
| 2018-09-30 | $932.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.82M derived: sum of 2 quarters · filed 2019-11-14 | $2.54M 10-Q · filed 2019-11-14 | $3.24M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $884.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.61M 10-Q · filed 2019-08-09 | $2.31M derived: sum of 3 quarters · filed 2019-08-09 | $2.96M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $728.00K 10-Q · filed 2019-05-15 | $1.42M derived: sum of 2 quarters · filed 2019-05-15 | $2.07M derived: sum of 3 quarters · filed 2019-05-15 | $2.71M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $695.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $1.34M derived: sum of 2 quarters · filed 2019-04-01 | $1.98M derived: sum of 3 quarters · filed 2019-04-01 | $5.60M 10-K · filed 2019-04-01 |
| 2017-09-30 | $649.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.28M derived: sum of 2 quarters · filed 2018-11-09 | $4.91M 10-Q · filed 2018-11-09 | $4.92M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $633.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-08 | $4.26M 10-Q · filed 2018-08-08 | $4.27M derived: sum of 3 quarters · filed 2018-08-08 | $4.28M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $3.62M 10-Q/A · filed 2018-08-08 | $3.64M derived: sum of 2 quarters · filed 2018-08-08 | $3.65M derived: sum of 3 quarters · filed 2018-08-08 | $3.66M derived: sum of 4 quarters · filed 2018-08-08 |
| 2016-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $27.00K derived: sum of 2 quarters · filed 2018-02-23 | $36.00K derived: sum of 3 quarters · filed 2018-02-23 | $45.00K 10-K · filed 2018-02-23 |
| 2016-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $18.00K derived: sum of 2 quarters · filed 2017-11-13 | $27.00K 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $18.00K 10-Q · filed 2017-08-11 | ||
| 2016-03-31 | $9.00K 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |